AstraZeneca Beats Market Expectations in the Third Quarter as Revenue Reaches $16.2 Billion
Pharmaceutical giant AstraZeneca exceeds market expectations in the third quarter.
BusinessPharmaceutical giant AstraZeneca exceeds market expectations in the third quarter.
BusinessAstra Zeneca's quarterly profit increases. Now the company management is raising its forecast for the full year 2024 and is making a major investment in the USA. The allegations against employees in China are being "taken very seriously", according to CEO Pascal Soriot.
Business